CareLit Fachartikel

Serum Interferon-gamma-inducible protein 10 (CXCL10) is a predictive marker of fibrosis progression after liver transplantation for hepatitis C infection

ML Berres, C Trautwein, M Schmeding, D Eurich, F Tacke, M Bahra, P Neuhaus, UP Neumann, HE Wasmuth · Zeitschrift für Gastroenterologie · 2011 · Heft 01

Dokument
1139444
CareLit-ID
Jahr
2011
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
ML Berres, C Trautwein, M Schmeding, D Eurich, F Tacke, M Bahra, P Neuhaus, UP Neumann, HE Wasmuth
Ausgabe
Heft 01 / 2011
Seiten
–
Erschienen: 2011-01-13 00:00:00
ISSN
0044-2771

Zusammenfassung

Aims: Recurrence of liver fibrosis after liver transplantation (LT) for hepatitis C infection (HCV) is responsible for graft loss and patient mortality. Although the contribution of the immune system to fibrosis recurrence is anticipated, systematic studies evaluating immune parameters as predictive markers of allograft fibrosis are lacking. The infiltration of immune cells into the graft is governed by different chemokines including CCL2 and the CXCR3 ligands CXCL9, CXCL10 and CXCL11. We here assessed the predictive value of serum levels of these chemokines with regards to fibrosis recurrence after LT for hepat…

Schlagworte

CXCL10 fibrosis recurrence hepatitis C infection liver transplantation After Chemokines Transplantation Hepatitis Association Chemokine Zeitschrift für Gastroenterologie